State Street
PGNX

State Street’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

State Street’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-4,635,469
Closed -$17.6M – 3897
2020
Q1 		$17.6M Buy
4,635,469
+240,458
+5% +$1.04M ﹤0.01% 1915
2019
Q4 		$22.4M Buy
4,395,011
+729,168
+20% +$3.86M ﹤0.01% 2073
2019
Q3 		$18.5M Sell
3,665,843
-839,691
-19% -$4.19M ﹤0.01% 2103
2019
Q2 		$27.8M Sell
4,505,534
-432,793
-9% -$2.09M ﹤0.01% 1885
2019
Q1 		$22.9M Sell
4,938,327
-213,201
-4% -$965K ﹤0.01% 1952
2018
Q4 		$21.6M Sell
5,151,528
-1,400,910
-21% -$7.13M ﹤0.01% 1926
2018
Q3 		$41.1M Buy
6,552,438
+2,383,914
+57% +$18.3M ﹤0.01% 1689
2018
Q2 		$33.5M Buy
4,168,524
+416,190
+11% +$3.18M ﹤0.01% 1770
2018
Q1 		$28M Buy
3,752,334
+301,401
+9% +$2M ﹤0.01% 1814
2017
Q4 		$20.5M Buy
3,450,933
+134,690
+4% +$818K ﹤0.01% 2024
2017
Q3 		$24.4M Sell
3,316,243
-392,545
-11% -$2.49M ﹤0.01% 1886
2017
Q2 		$25.2M Buy
3,708,788
+1,110,067
+43% +$8.19M ﹤0.01% 1827
2017
Q1 		$24.5M Buy
2,598,721
+537,739
+26% +$5.37M ﹤0.01% 1788
2016
Q4 		$17.8M Sell
2,060,982
-509,295
-20% -$3.76M ﹤0.01% 1984
2016
Q3 		$16.3M Buy
2,570,277
+555,319
+28% +$3.36M ﹤0.01% 1902
2016
Q2 		$8.5M Sell
2,014,958
-65,701
-3% -$317K ﹤0.01% 2312
2016
Q1 		$9.07M Sell
2,080,659
-266,232
-11% -$1.19M ﹤0.01% 2232
2015
Q4 		$14.4M Sell
2,346,891
-2,151,246
-48% -$14.1M ﹤0.01% 1956
2015
Q3 		$25.7M Sell
4,498,137
-442,887
-9% -$3.4M ﹤0.01% 1585
2015
Q2 		$36.9M Buy
4,941,024
+813,677
+20% +$4.92M ﹤0.01% 1446
2015
Q1 		$24.7M Buy
4,127,347
+967,454
+31% +$6.09M ﹤0.01% 1701
2014
Q4 		$23.9M Buy
3,159,893
+2,160,701
+216% +$12.9M ﹤0.01% 1670
2014
Q3 		$5.19M Buy
999,192
+3,256
+0.3% +$16.2K ﹤0.01% 2529
2014
Q2 		$4.29M Buy
995,936
+1,522
+0.2% +$5.81K ﹤0.01% 2672
2014
Q1 		$4.07M Buy
994,414
+110,233
+12% +$564K ﹤0.01% 2693
2013
Q4 		$4.71M Buy
884,181
+20,209
+2% +$88.9K ﹤0.01% 2611
2013
Q3 		$4.35M Buy
863,972
+134,004
+18% +$727K ﹤0.01% 2614
2013
Q2 		$3.26M Buy
+729,968
New +$3.28M ﹤0.01% 2695

Other funds holding PGNX

ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $49.2B AUM 29.3% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

State Street's PGNX Position: Q2 2020 in Review

State Street sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2020, closing a stake of 4,635,469 shares — an estimated $17.6M sold.

State Street first reported a position in PGNX in Q2 2013 and held it in 28 quarters. The position peaked at $41.1M in Q3 2018. 3 funds tracked by Wall St. Rank hold PGNX as of Q2 2020.

  • State Street reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
  • State Street sold 4,635,469 Progenics Pharmaceuticals Inc shares in Q2 2020, an estimated $17.6M.
  • State Street first reported a position in Progenics Pharmaceuticals Inc in Q2 2013 and held it in 28 quarters.
  • State Street's Progenics Pharmaceuticals Inc position peaked at $41.1M in Q3 2018.
  • 3 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2020.

Based on State Street's 13F filing for Q2 2020, filed 14 Aug 2020.